Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

RussNeft reported for 6 months of 2023 by IFRS

8/25/23 RNFT

Moscow Exchange is interested in buying Banki.ru, but is not satisfied with the price

8/25/23 MOEX

Rosneft has developed a new hydraulic fracturing technology

8/25/23 ROSN

TEK reported for 6 months of 2023 by IFRS

8/25/23 TASB

Rostelecom received 35.2% in the multibanking platform Fazum

8/25/23 RTKM

Board of Directors of Novatek recommended that dividends be paid for 6 months 2023

8/25/23 NVTK

KSC reported for 6 months of 2023 by IFRS

8/25/23 KTSB

NKHP reported for 6 months of 2023 by IFRS

8/25/23 NKHP

Cherkizovo bought acquired 10 thousand hectares of agricultural land in the Tula region

8/25/23 GCHE

TRK reported for 6 months of 2023 by IFRS

8/25/23 TORS